A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP)

NCT06646289 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

X-Linked Retinitis Pigmentosa

Interventions

BIOLOGICAL: AAV5-hRKp.RPGR
OTHER: No intervention (Follow-Up assessment)

Sponsor

Janssen Research & Development, LLC